<?xml version="1.0" encoding="UTF-8"?>
<p id="p0350">IIV is recommended for all patients older than 6 months with hematologic malignancies, although IDSA guidelines do not recommend vaccination in patients receiving intensive chemotherapy, such as induction or consolidation chemotherapy for acute leukemia, or those who have received antiâ€“B-cell antibodies in the past 6 months.
 <xref rid="bib_23" ref-type="bibr">
  <sup>23</sup>
 </xref> Although immune responses are generally lower in children with malignancies, a recent Cochrane review demonstrated reductions in respiratory infections and hospitalization; however, the quality of evidence is low.
 <xref rid="bib_26" ref-type="bibr">
  <sup>26</sup>
 </xref>
</p>
